Injective (INJ) is currently priced at $2.87, reflecting a slight decline of 0.38% over the past 24 hours. The price has fluctuated between a high of $2.91 and a low of $2.84 in the same timeframe, indicating a daily range of just 0.07%, which suggests a period of relative stability.

The trading volume over the past 24 hours stands at approximately 41.28 million, resulting in a volume-to-market cap ratio of 14.36%. This volume indicates a healthy level of trading activity, though it is essential to note that the recent price movements have shown a downward trend, particularly with a 7-day RSI of 45, signaling potential bearish momentum.

Moving averages indicate a mixed outlook; the 8 SMA is at $2.88 (-0.40%), while the longer-term 144 SMA is at $2.89 (-0.73%). The short-term averages suggest a slight bearish sentiment, but the current price is still trading close to these averages, reflecting a potential area of support around $2.87.

Over the past week, INJ has seen a price decline of about 6.38%, with a more significant drop of 11.66% over the past 14 days. The longer-term trend also shows a decrease of approximately 5.99% over the last 30 days, indicating persistent selling pressure that could be weighing on investor sentiment.

The all-time high of $52.62 reached in March 2024 is a stark contrast to the current price level, indicating substantial retracement. The large gap between the current price and the all-time high presents both a risk and an opportunity; however, the recent negative price trends must be addressed for any upward movement to be sustainable.

Considering the technical indicators, current price action, and volume dynamics, a cautious approach is warranted. Therefore, the rating for Injective (INJ) is a Hold, as potential for recovery exists, but further confirmation of a trend reversal is necessary before making a bullish stance.